Prostate Cancer Treatment Market Segmentation
Prostate Cancer Treatment Market Drug Type Outlook (USD Billion, 2018-2032)
Prostate Cancer Treatment Market Distribution Channel Outlook (USD Billion, 2018-2032)
Prostate Cancer Treatment Market Regional Outlook (USD Billion, 2018-2032)
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE
6.1. Overview
6.2. Hormonal Therapy
6.3. Chemotherapy
6.4. Immunotherapy
6.5. Targeted Therapy
6.6. Others
7. PROSTATE CANCER TREATMENT MARKET,BY DISTRIBUTION CHANNEL
7.1. Overview
7.2. Hospital Pharmacies
7.3. Drug Stores & Retail Pharmacies
7.4. Online Pharmacies
8. PROSTATE CANCER TREATMENT MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Prostate Cancer Treatment Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Prostate Cancer Treatment Market,
9.7. Key developments and Growth Strategies
9.7.1. New Drug TypeLaunch/Service Deployment
9.7.2. Merger &Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income,2022
9.8.2. Major Players R&D Expenditure.2022
10. COMPANY PROFILES
10.1. Johnson & Johnson;
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Drug Types Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Services Inc.;
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Drug Types Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Astellas Pharma Inc.;
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Drug Types Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Eli Lilly and Company;
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Drug Types Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Sanofi;
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Drug Types Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Ipsen Pharma;
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Drug Types Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Bayer AG;
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Drug Types Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. AstraZeneca;
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Drug Types Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Valeant Pharmaceuticals International, Inc.;
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Drug Types Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Merck & Co., Inc.;
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Drug Types Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Pfizer Inc;
10.11.1. Company Overview
10.11.2. Financial Overview
10.11.3. Drug Types Offered
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 PROSTATE CANCER TREATMENT MARKET, SYNOPSIS, 2018-2032
TABLE 2 PROSTATE CANCER TREATMENT MARKET, ESTIMATES &FORECAST, 2018-2032(USD BILLION)
TABLE 3 PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 4 PROSTATE CANCER TREATMENT MARKET,BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: PROSTATE CANCER TREATMENT MARKET,BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 7 US: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 8 US: PROSTATE CANCER TREATMENT MARKET,BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 9 CANADA: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 10 CANADA: PROSTATE CANCER TREATMENT MARKET,BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 3 GERMANY: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE,2018-2032 (USD BILLION)
TABLE 4 GERMANY: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 5 FRANCE: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 6 FRANCE: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 7 ITALY: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 8 ITALY: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 9 SPAIN: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 10 SPAIN: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 11 UK: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 12 UK: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 17 JAPAN: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 18 JAPAN: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 19 CHINA: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 20 CHINA: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 21 INDIA: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 22 INDIA: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 23 AUSTRALIA: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 24 AUSTRALIA: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 33 AFRICA: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 34 AFRICA: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: PROSTATE CANCER TREATMENT MARKET,BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: PROSTATE CANCER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE PROSTATE CANCER TREATMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE PROSTATE CANCER TREATMENT MARKET
FIGURE 4 PROSTATE CANCER TREATMENT MARKET, SHARE (%), BY DRUG TYPE, 2022
FIGURE 5 PROSTATE CANCER TREATMENT MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 6 PROSTATE CANCER TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 7 NORTH AMERICA: PROSTATE CANCER TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 EUROPE: PROSTATE CANCER TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 ASIA-PACIFIC: PROSTATE CANCER TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 REST OF THE WORLD: PROSTATE CANCER TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 PROSTATE CANCER TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 12 JOHNSON & JOHNSON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 JOHNSON & JOHNSON: SWOT ANALYSIS
FIGURE 14 SERVICES INC.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 SERVICES INC.:SWOT ANALYSIS
FIGURE 16 ASTELLAS PHARMA INC.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 ASTELLAS PHARMA INC.:SWOT ANALYSIS
FIGURE 18 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 ELI LILLY AND COMPANY:SWOT ANALYSIS
FIGURE 20 SANOFI:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 SANOFI:SWOT ANALYSIS
FIGURE 22 IPSEN PHARMA:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 IPSEN PHARMA:SWOT ANALYSIS
FIGURE 24 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 BAYER AG: SWOT ANALYSIS
FIGURE 26 ASTRAZENECA:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 ASTRAZENECA:SWOT ANALYSIS
FIGURE 28 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.:SWOT ANALYSIS
FIGURE 30 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 MERCK & CO., INC.:SWOT ANALYSIS
FIGURE 32 PFIZER INC:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 PFIZER INC:SWOT ANALYSIS
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
